research

Viking Therapeutics’ inventory greater than doubles as traders cheer low cost entry to weight-loss-drug craze

This stock-fund supervisor outperforms with ‘fixer-uppers’

Sharing COVID remedy secrets and techniques is a Trojan horse that will intestine U.S. biotech

This fast-growing nation is taming inflation and in robust monetary form — and its inventory market is looking

Iovance inventory drops 24% after it halts cancer-drug trial

Five obesity-drug tendencies to observe in 2024: Who can compete with Eli Lilly and Novo Nordisk? 

Sanofi suffers main blow as its cutting-edge most cancers drug disappoints in Phase III trials

Roche strikes $3.1 billion deal to purchase obesity-drug maker Carmot Therapeutics in race to rival Novo Nordisk’s Ozempic

Novo Nordisk’s Wegovy cuts danger of coronary heart assault and stroke by 20% amongst folks with out diabetes, examine finds

Eli Lilly will get FDA approval for brand spanking new weight problems drug